Patent Application
Provisional
App. No. 62/488,528
· Confirmation No. 9817
CO-ADMINISTRATION OF MINOCYCLINE AND COLISTIN TO REDUCE ACUTE KIDNEY INJURY
Applicant:
Rempex Pharmaceuticals, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2017-05-03 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2017-04-21 | SPEC |
Specification | 38 | View | |
| 2017-04-21 | CLM |
Claims | 5 | View | |
| 2017-04-21 | ABST |
Abstract | 1 | View | |
| 2017-04-21 | ADS |
Application Data Sheet | 8 | View | |
| 2017-04-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-04-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Michael N. Dudley
San Diego, CA
David C. Griffith
San Marcos, CA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 20995
- Docket No.
- REMPEX.128PR2
- Confirmation No.
- 9817
from
CEMPRA PHARMACEUTICALS, INC.,
MELINTA SUBSIDIARY CORP.,
MELINTA THERAPEUTICS, INC.,
REMPEX PHARMACEUTICALS, INC.
SECURITY INTEREST
Recorded 2018-07-25
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2018-01-05
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/488,528
- Filed
- 2017-04-21
External Links